The global network has expanded gradually over the past several years. After establishing production bases in South Korea and China, Osstem later added manufacturing capacity in the US. In 2024, the company further strengthened its presence in the Americas through the acquisition of the Brazilian implant manufacturer Implacil. With the Brazilian facility now integrated into its operations, Osstem states that it operates a four-region manufacturing network spanning Asia, North America and South America.
The company has also invested in expanding its research infrastructure. In 2025, Osstem completed the Triple Tower, a complex dedicated to research and development located in Songdo International City in South Korea. The project forms part of the company’s efforts to support next-generation technological development and strengthen its research capabilities.
A central element of Osstem’s strategy is its internal quality management system. According to the company, its internal standards exceed international manufacturing quality standards and it currently maintains a quality target of under 100 parts per million—equivalent to fewer than one defect per 10,000 units.
To support this objective, the company operates a six-major key process management system alongside a five-stage precision inspection process that includes self-inspection, machining inspection, surface inspection, incoming inspection and final shipping inspection. According to Osstem, these procedures are designed to ensure product consistency and minimise defects. Manufacturing facilities also incorporate controlled environments, including cleanrooms and deionised water systems, and the company operates a quality management framework designed to respond rapidly to customer feedback.
The company has also continued to expand its investment in research and development. According to Osstem, more than 10% of its annual revenue is allocated to research and innovation activities. Approximately 900 researchers currently work across 15 specialised institutes within the Osstem Central Research Institute, focusing on implants, dental equipment, materials, orthodontics and digital dentistry. According to the company, these investments support the development of a broad portfolio of products for dental treatment, positioning Osstem as a provider of integrated dental solutions.
At this year’s AEEDC Dubai, which was held in January, the company presented its SOI implant system and digital dentistry solutions. According to Osstem, dentists attending the event described the technologies as “innovative technologies that dramatically shorten the healing period”.
